Login
Navigate Fool.com
Will SLTM beat
the market?

Solta Medical, Inc.

NASDAQ: SLTM

Community Rating: 2 Stars: Unattractive

0.00 0.00 (0.00%)

Quote as of

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open 0.00
Previous Close 0.00
Daily Range 0.00 - 0.00
52-Week Range 0.00 - 0.00
Market Cap 0.0000
P/E Ratio 97.33
Dividend (Yield) 0.00 (0.0%)
Volume 0
Average Daily Volume 0
Current FY EPS -0.08

How do you think SLTM
will perform against the market?

Top SLTM Bull/Bear Pitches

 

OneStarHero (0.33)
Submitted May 27, 2007

The treatment is a scam, but women are stupid. Up up and away.

4 Replies Reply Report this Post
 

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches here!

News & Commentary Rss Feed

Why Valeant Pharmaceuticals Intl. Inc. Shares Popped

Valeant introduces its fiscal 2014 guidance.

TSX Down 31 Points At Midday; Financials, Miners Biggest Decliners After China Data

3 Companies Revolutionizing the Cosmetics Industry

How are Allergan, Valeant, and Zeltiq revolutionizing the cosmetics industry, and how can their new procedures help patients fight the classic problems of aging and excess body fat?

Mid-Afternoon Market Update: Markets Rise as Twitter Pulls Back

Mid-Day Market Update: LSI Surges On Acquisition News; T-Mobile Shares Slip

Activist Investors Seeking to Force Sale Of Solta Medical

Strong Acquisition Target Poised To Challenge In Fat Loss And Skin Care Markets

Voce Capital’s Latest Public Letter To Solta Directors Demands Sale Of Company

Voce Capital Pushes For Acquisition Of Solta Medical, Activist Investor David Callan Joins In

Coming Soon: Solta Medical Earnings

Checking expectations

See More SLTM News...

Sector

Healthcare

Industry

Healthcare Information Services

Solta Medical, Inc. (SLTM) Description

The Company designs, develops, manufactures and markets medical devices for the non-invasive treatment of wrinkles. Website: http://www.solta.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks